- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 213,693,704
- Share change
- +608,169
- Total reported value
- $90,176,303,862
- Put/Call ratio
- 182%
- Price per share
- $422.24
- Number of holders
- 961
- Value change
- +$321,462,904
- Number of buys
- 454
- Number of sells
- 406
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
13%
|
19,788,113
|
$6,717,074,000 | — | 31 Dec 2014 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
12%
|
17,170,693
|
$5,828,592,000 | — | 31 Dec 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
12,730,694
|
$4,321,434,000 | — | 31 Dec 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.3%
|
12,176,548
|
$4,133,329,000 | — | 31 Dec 2014 | |
| STATE STREET CORP |
13F
|
Company |
6.9%
|
10,105,791
|
$3,430,422,000 | — | 31 Dec 2014 | |
| Clearbridge Investments, LLC |
13F
|
Company |
5.6%
|
8,231,670
|
$2,794,241,000 | — | 31 Dec 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.7%
|
6,974,966
|
$2,367,652,000 | — | 31 Dec 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
4.3%
|
6,266,811
|
$2,127,269,000 | — | 31 Dec 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.8%
|
5,619,663
|
$1,907,595,000 | — | 31 Dec 2014 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.4%
|
4,974,331
|
$1,688,537,000 | — | 31 Dec 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
3.1%
|
4,534,594
|
$1,539,268,000 | — | 31 Dec 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.3%
|
3,358,853
|
$1,140,554,000 | — | 31 Dec 2014 | |
| Invesco Ltd. |
13F
|
Company |
2.3%
|
3,342,751
|
$1,134,697,000 | — | 31 Dec 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.1%
|
3,145,256
|
$1,067,657,000 | — | 31 Dec 2014 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
2%
|
2,900,674
|
$984,633,000 | — | 31 Dec 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.9%
|
2,769,523
|
$940,112,000 | — | 31 Dec 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.8%
|
2,711,313
|
$920,358,000 | — | 31 Dec 2014 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
1.8%
|
2,679,722
|
$909,683,000 | — | 31 Dec 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.7%
|
2,535,845
|
$860,792,000 | — | 31 Dec 2014 | |
| BlackRock Group LTD |
13F
|
Company |
1.5%
|
2,195,060
|
$745,113,000 | — | 31 Dec 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
2,126,484
|
$721,838,000 | — | 31 Dec 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.4%
|
2,072,866
|
$703,634,000 | — | 31 Dec 2014 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.3%
|
1,910,158
|
$648,403,000 | — | 31 Dec 2014 | |
| Winslow Capital Management, LLC |
13F
|
Company |
1.3%
|
1,909,997
|
$648,348,000 | — | 31 Dec 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,861,665
|
$631,165,000 | — | 31 Dec 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,802,529
|
$611,869,000 | — | 31 Dec 2014 | |
| Capital World Investors |
13F
|
Company |
1.2%
|
1,710,500
|
$580,629,000 | — | 31 Dec 2014 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,645,805
|
$558,669,000 | — | 31 Dec 2014 | |
| MARSICO CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,607,156
|
$545,549,000 | — | 31 Dec 2014 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.1%
|
1,576,365
|
$535,097,000 | — | 31 Dec 2014 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,568,496
|
$532,425,000 | — | 31 Dec 2014 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
1%
|
1,523,240
|
$517,064,000 | — | 31 Dec 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
1,494,700
|
$507,376,000 | — | 31 Dec 2014 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.98%
|
1,446,949
|
$491,166,837 | — | 31 Dec 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.83%
|
1,224,670
|
$415,714,000 | — | 31 Dec 2014 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.82%
|
1,201,289
|
$407,778,000 | — | 31 Dec 2014 | |
| MANAGED ACCOUNT ADVISORS LLC |
13F
|
Company |
0.71%
|
1,037,556
|
$352,198,000 | — | 31 Dec 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.65%
|
949,917
|
$322,444,000 | — | 31 Dec 2014 | |
| Legal & General Group Plc |
13F
|
Company |
0.64%
|
940,927
|
$319,407,000 | — | 31 Dec 2014 | |
| MONTAG & CALDWELL, LLC |
13F
|
Company |
0.63%
|
923,072
|
$313,337,000 | — | 31 Dec 2014 | |
| DSM CAPITAL PARTNERS LLC |
13F
|
Company |
0.61%
|
898,165
|
$304,883,000 | — | 31 Dec 2014 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.56%
|
830,694
|
$281,980,000 | — | 31 Dec 2014 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.56%
|
829,459
|
$281,559,000 | — | 31 Dec 2014 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.5%
|
741,610
|
$265,415,000 | — | 31 Dec 2014 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.53%
|
781,758
|
$265,368,000 | — | 31 Dec 2014 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.53%
|
780,187
|
$264,835,000 | — | 31 Dec 2014 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.49%
|
718,748
|
$243,979,000 | — | 31 Dec 2014 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.49%
|
714,165
|
$242,424,000 | — | 31 Dec 2014 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.47%
|
696,116
|
$236,297,000 | — | 31 Dec 2014 | |
| AJO, LP |
13F
|
Company |
0.46%
|
677,140
|
$229,855,000 | — | 31 Dec 2014 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2015
As of 31 Mar 2015,
BIOGEN INC. - Common Stock (BIIB) was held by
961 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
213,693,704 shares.
The largest 10 holders included
FMR LLC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Clearbridge Investments, LLC, BlackRock Institutional Trust Company, N.A., JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, and SANDS CAPITAL MANAGEMENT, LLC.
This page lists
962
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
877
Q1 2015 holders
961
Holder diff
84
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.